Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Prenetics Global Limited

Prenetics Global Limited (PRE) Stock Overview

Explore Prenetics Global Limited’s financial performance, market position, analyst ratings, and future outlook.

PRE●NASDAQ
HealthcareMedical - Diagnostics & Research
$20.20
$2.23(12.41%)
U.S. Market opens in 63h 19m

Prenetics Global Limited (PRE)

Meyka AI Score

Z

Key Financials

Market Cap343.4M
P/E Ratio-4.93
EPS (TTM)$-4.05
ROE-0.49%
Fundamental Analysis

AI Price Forecasts

1 Month$19.54
3 Months$24.51
1 Year Target$23.40

PRE Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Prenetics Global Limited (NASDAQ: PRE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Prenetics Global Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PRE on the NASDAQ shows an RSI of 57.59, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $23.40 for the NASDAQ listing.

Key metrics behind Prenetics Global Limited's NASDAQ-traded stock include a P/E ratio of -4.93 and a market capitalization of 343.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRE on the NASDAQ.

Price Performance (NASDAQ: PRE)

1-Day Change
12.41%
5-Day Change
1.00%
1-Month Change
-8.43%
3-Month Change
26.88%
6-Month Change
18.48%
Year-to-Date (YTD) Change
28.25%
1-Year Change
177.09%
3-Year Change
143.37%
5-Year Change
-82.03%
All-Time (Max) Change
-82.27%

Contact Information

https://www.prenetics.com
852 2210 9588
Unit 701-706, K11 Atelier King’s Road, Hong Kong, NaN, NaN

Company Facts

980 Employees
IPO DateJul 16, 2021
CountryHK
Actively Trading

Frequently Asked Questions